Arrakis Therapeutics Inc.

Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more

Plus: CMO changes at Sunbird and Cidara, and updates from Aicuris, Renovaro, Noema and more

Company also adds Friberg to lead R&D, continuing the rebuild of its leadership team with former Genentech, Roche, Amgen execs

Pharma has struck multiple 10-figure deals under Sabry’s watch, expands role for BD head Boris Zaitra

In new role, the VC aims to combine elements of academic background with industry knowledge to create and develop new medicines

Plus: Granaturova becomes COO and CBO at Normunity, and updates from 

$52M round led by AstraZeneca’s joint fund with China International Capital 

New publications highlight bispecific antibody degraders as a way to eliminate a cell surface target

Diagnostics chief inherits kernels of digital growth, with revenues and pipeline to ease the path

Plus Sallah joins Genespire as CMO, and updates from Kinaset, Andera, Ariceum and more